Back
PAA
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Pharmaust Limited
π¦πΊ ASX
π¦ LOGISTICS
π HIGH PRICE GROWTH
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
+ 15.38%
Annual Growth
5 years average annual capital growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
20
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
PharmAust Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-10-05. The Companyβs segments include Corporate and Research. The firm is focused on repurposing monepantel (MPL) for human neurodegenerative diseases. The firm's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway, that plays a central role in cell growth and proliferation of cancer cells and in degenerating neurons. The firm is also developing MPL as a treatment for motor neuron disease (MND/ALS), a rare, incurable disease. The company is focused on starting Phase II/III clinical study of MPL. The company has also completed a Phase II oncology clinical study of MPL in humans and pilot studies in canine cancer. The company is also preparing a pivotal monepantel field trial in dogs with B-Cell Lymphoma to enable product registration in the United States.
π Performance
Price History
+2434.99%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$0.23
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in PAA
0
π Total Capital Earnings
$53K
π Average investment frequency
30 weeks
π΅ Average investment amount
$1,711
β° Last time a customer invested in PAA
364 days
PAA investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
35 - 90
π Legal gender of investors
Female
Male
Pearlers who invest in PAA also invest in...
Neurizon Therapeutics Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-10-05. The firm is engaged in advancing treatments for neurodegenerative diseases. The firm is focused on developing its lead drug candidate, NUZ-001, for the treatment of Amyotrophic Lateral Sclerosis (ALS), which is the common form of motor neuron disease. ALS is a devastating neurodegenerative condition that primarily affects nerve cells that control voluntary muscles.
π Share price
$0.14 AUD
π¦ LOGISTICS
Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. The company is headquartered in Perth, Western Australia. The Companyβs lead product is Sofdra (sofpironium) topical gel, 12.45%, a prescription anticholinergic medicine used on the skin (topical), to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children nine years of age and older. Sofdra regulates sweating at the site of application, by binding to the primary sweat receptor and thereby blocking the sweat signal. Its product pipeline targets the various skin diseases, such as BTX 1503 for Acne, BTX 1702 for Rosacea, BTX 1204A for Atopic Dermatitis, and BTX 1801 for Hemodialysis Patients. Its BTX 1503 is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. BTX 1702 is used for the treatment of papulopustular rosacea. BTX 1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus (MRSA).
π Performance (5Yr p.a)
6.82%
π Share price
$0.15 AUD
π¦ LOGISTICS
South32 Ltd. operates as a metal and mining company. The company is headquartered in Perth, Western Australia and currently employs 8,892 full-time employees. The company went IPO on 2015-05-18. Its segments include Worsley Alumina, Brazil Alumina, Brazil Aluminium, Hillside Aluminium, Mozal Aluminium, Sierra Gorda, Cannington, Hermosa, Cerro Matoso, Australia Manganese and South Africa Manganese. Worsley Alumina segment includes an integrated bauxite mine and an alumina refinery in Australia. Brazil Alumina segment consists of an integrated bauxite mine and an alumina refinery in Brazil. Brazil Aluminium segment is engaged in aluminum smelter in Brazil. Hillside Aluminium segment is focused on aluminum smelter in South Africa. Mozal Aluminium segment is engaged in aluminum smelter in Mozambique. Sierra Gorda segment is focused on copper mine in Chile. Cannington segment includes silver, lead and zinc mines in Australia. Hermosa segment includes base metals exploration and development project in the United States. Cerro Matoso segment includes an integrated laterite ferronickel mine and smelting complex in Colombia.
π Performance (5Yr p.a)
8.38%
π Share price
$3.06 AUD
π HIGH PRICE GROWTH
βοΈ MINING
Fortescue Ltd. engages in the development of iron ore deposits. The company is headquartered in Perth, Western Australia. The firm's segments include Metals and Energy. Metals segment includes exploration, development, production, processing, sale and transportation of iron ore, and the exploration for other minerals. Its metals business comprises its iron ore operations in the Pilbara as well as a pipeline of exploration projects globally including in Gabon in Africa, Latin America and Australia. The firm's metals business includes Hedland operations, Chichester Hub, Western Hub, Iron Bridge, Green Metal Project, integrated operations, Belinga Project, Blacksmith Project and Pilbara Energy Connect (PEC) project. Energy segment undertakes activities in the global development of green electricity, green hydrogen, green ammonia projects, as well as green technology development and manufacturing. Its energy business includes Arizona Hydrogen project, Holmaneset project, Pecem project and Gladstone PEM50 Project.
π Performance (5Yr p.a)
3.03%
π Share price
$19.14 AUD
ποΈ SOCIALLY AWARE
π° HIGH DIVIDEND
βοΈ MINING
Red 5 Ltd. is a gold exploration and mining company, which engages in the development and exploration of mineral properties. The company is headquartered in Perth, Western Australia. The firm operates in four established mining hubs of scale in tier 1 gold jurisdictions of Western Australia and Ontario, which consists of King of the Hills Operations, Deflector Operations, Mount Monger Operations, and Sugar Zone Project. The King of the Hills Gold Mine is located 28km north of the town of Leonora. The Deflector Gold Copper Mine (Deflector) is located in the southern Murchison region of WA, 450km north of Perth and 160km east of the Western Australian regional city of Geraldton. The Mount Monger goldfield is located 50 km southeast of Kalgoorlie and is accessible via the Mount Monger road which is bitumen for 15 km then an all weather road for the remaining 35 km. The Sugar Zone mine is high grade underground mine in Northern Ontario, approximately 30km north of White River or midway between Thunder Bay and Sault St. Marie.
π Performance (5Yr p.a)
3.60%
π Share price
$0.34 AUD
βοΈ MINING
Want more shares? Try these...